ArticleParasites & vectors2026
Diagnostic potential of a multi-antigen ELISA for feline leishmaniosis.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Strategic surveillance plan for zoonotic leishmaniosis in Portugal.One health (Amsterdam, Netherlands) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundLeishmania infantum is a sand fly-transmitted zoonotic protozoan, endemic in the Mediterranean basin and responsible for human, canine (CanL), and feline (FeL) leishmaniosis. While dogs are the primary reservoir host, a growing number of FeL cases have been reported in this region despite the absence of pathognomonic clinical signs and limited diagnostic tools. Herein, we evaluate the performance of seven serological tools for CanL in detecting antibodies to Leishmania in cats, aiming to improve FeL diagnosis.
methodsFive ELISAs based on Leishmania-specific antigens (soluble promastigote Leishmania antigens, SPLA; recombinant Leishmania proteins K39 [rK39], K28, and KDDR, and L. infantum cytosolic peroxiredoxin, LicTXNPx), indirect fluorescent antibody test (IFAT), and direct agglutination test (DAT) were compared for detecting anti-Leishmania antibodies in 274 cats. Blood samples from the same cats were molecularly tested. Statistical analysis was performed based on clustering of multivariate serological data. Reference serological profiles were first defined in a control group. Study group data were subsequently classified according to these profiles, with principal component analysis used for dimensionality reduction and graphical representation. Associations between seropositivity and clinicopathological alterations were determined using seropositivity thresholds.
resultsCats exhibited attenuated and heterogeneous antibody responses to L. infantum serological tests. Agreement between individual tests was variable, with poor concordance when single markers were considered. Multivariate analysis, based on clustering of serological responses, showed that positivity to multiple antigens was associated with clinically affected cats. Positivity to multiple Leishmania-specific ELISA antigens was associated with diverse clinical presentations and prognostic laboratory alterations, including anaemia, thrombocytopenia, and hypergammaglobulinaemia.
conclusionsIntegrating multi-antigen ELISA, particularly rK39, SPLA, and LicTXNPx, into FeL diagnostic workflows, alongside molecular and clinical assessment, improves epidemiological surveillance, early detection, and disease management. These findings support the development of serological strategies tailored to feline hosts for enhanced surveillance and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.